Lumida
/ALLO
⌘K
Allogene Therapeutics Inc

Allogene Therapeutics Inc

ALLO
$1.78USD+1.14%+0.02 today

MARKET CAP

615.0M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$1
$4

AI Summary

Stalk
TrimMedium

Following a Stage 1 consolidation attempt after a terminal decline, the stock exhibits a repaired EMA regime yet remains under an active Lower Highs & Lower Lows pattern, reinforcing a medium-term bearish bias. In the short term, price is tightly tracking above the rising 9/21-EMA zone without a clear rejection signal, arguing for patience and deferred execution until a more decisive breakdown or EMA rejection occurs.

  • Phase 2 ALPHA3 trial cema-cel shows 58.3% MRD negativity vs 16.7% control.
  • FDA granted RMAT and Fast Track designations, expediting approval path.
  • Negative earnings yield and profitability scores signal weak returns.
Full analysis →

Buying

8

institutions

Selling

6

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY30.15 M62.71 M+11.06 M+34.6%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY10.22 M21.26 M+3.34 M+26.5%0.00%
MM

Millennium Management LLC

Q2 2026

BUY4.84 M10.08 M+1.52 M+24.3%0.00%
WP

Woodline Partners LP

Q2 2026

SELL4.50 M9.36 M+-2.50 M-45.2%0.03%
RT

Renaissance Technologies LLC

Q2 2026

BUY3.83 M7.98 M+1.69 M+52.8%0.01%
RI

Rtw Investments, LP

Q2 2026

BUYNEW3.25 M6.76 M+3.25 M+0.0%0.06%
AC

Aqr Capital Management LLC

Q2 2026

SELL2.01 M4.17 M+-478.49 K-31.2%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.44 M3.19 M+3.79 K+0.3%0.00%
MG

Man Group Plc

Q2 2026

BUY701.90 K1.46 M+547.22 K+286.8%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL39.02 K81.16 K+-23.39 K-46.7%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUYNEW23.15 K49.00 K+23.15 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL12.50 K26.00 K+-1.37 K-23.2%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-1.18 M-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-221.34 K-100.0%0.00%